Can pelvic exams help diagnose STDs in girls?

Image
ANI Washington D.C. [USA]
Last Updated : Jul 04 2018 | 12:50 PM IST

Pelvic exams do not help in diagnosing sexually transmitted diseases (STDs) in adolescent girls, according to a study.

"Sexually transmitted disease rates for adolescent women are reaching their highest recorded rate," said Cena Tejani, lead study author.

"Pelvic exams lack reliability and provide very little new information when compared with other methods of diagnosis. A closer review of STD diagnosis protocol could benefit the health and well-being of adolescent women all over the country."

Out of 288 patients in an observational analysis, pelvic exam results did not change the clinician's decision to treat a large majority (217 of the cases) with antibiotics.

There were 79 patients with chlamydia, gonorrhea or trichomonas vaginal infections, according to positive urinalyses.

The pelvic exam information did influence the case management in 71 instances, 35 of which correlated with the STD tests while 36 did not. The pelvic exam information did not consistently help the physicians better identify whether the patient was STD positive or negative, the study found.

The study confirmed that pelvic exams do not increase the sensitivity or specificity of diagnosis.

Practitioners may choose to perform pelvic exams, because urine test results are not immediately available, the study authors note.

"Patients that receive pelvic exams may sometimes be unaccompanied minors, and sexual health -- especially for an adolescent girl -- can be a very sensitive topic," said Dr. Tejani.

"As physicians, it is important to be aware of the limitations of pelvic exam data and the impact that these invasive procedures have on some patients."

"Rapid urine STD testing provides a more accurate less invasive way to diagnose these diseases. Hospitals should strongly consider purchasing these tests to better evaluate young women with STDs," said Dr. Tejani.

The study appeared in the journal Annals of Emergency Medicine.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jul 04 2018 | 12:50 PM IST

Next Story